Category

Cohort News

PharmaJet’s Needle-free Injection System Selected to Administer DNA Immunotherapy for Advanced Melanoma in Late-stage Clinical Development following Positive Phase 2 Data

//
Categories
PharmaJet’s intramuscular (IM) Needle-free Injection System – Stratis® – was used to deliver Scancell’s iSCIB1+ DNA immunotherapy in combination with immune checkpoint inhibitors in the SCOPE Phase 2 trial. The Scancell immunotherapy delivered using PharmaJet’s Stratis demonstrated a Progression-Free Survival...
Read More →